1
|
Jena S, Gonzalez G, Vítek D, Kvasnicová M, Štěpánková Š, Strnad M, Voller J, Chanda K. Novel neuroprotective 5,6-dihydropyrido[2',1':2,3]imidazo[4,5-c]quinoline derivatives acting through cholinesterase inhibition and CB2 signaling modulation. Eur J Med Chem 2024; 276:116592. [PMID: 39013357 DOI: 10.1016/j.ejmech.2024.116592] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/05/2024] [Revised: 05/31/2024] [Accepted: 06/09/2024] [Indexed: 07/18/2024]
Abstract
A novel group of 5,6-dihydropyrido [2',1':2,3]imidazo [4,5-c]quinolines was prepared via a microwave assisted one-pot telescopic approach. The synthetic sequence involves the formation of an amine precursor of imidazo [1,2-a]pyridine via condensation and reduction under microwave irradiation. Subsequently, the Pictet-Spengler cyclisation reaction occurs with ketones (cyclic or acyclic) to obtain substituted 5,6-dihydropyrido [2',1':2,3]imidazo [4,5-c]quinolines in excellent yields. The compounds were tested as neuroprotective agents. Observed protection of neuron-like cells, SH-SY5Y differentiated with ATRA, in Parkinson's and Huntington's disease models inspired further mechanistic studies of protective activity against damage induced by 1-methyl-4-phenylpyridinium (MPP+), a compound causing Parkinson's disease. The novel compounds exhibit similar or higher potency than ebselen, an established drug with antioxidant activity, in the cells against MPP + -induced total cellular superoxide production and cell death. However, they exhibit a significantly higher capacity to reduce mitochondrial superoxide and preserve mitochondrial membrane potential. We also observed marked differences between a selected derivative and ebselen in terms of normalizing MPP + -induced phosphorylation of Akt and ERK1/2. The cytoprotective activity was abrogated when signaling through cannabinoid receptor CB2 was blocked. The compounds also inhibit both acetylcholine and butyrylcholine esterases. Overall the data show that novel 5,6-dihydropyrido [2',1':2,3]imidazo [4,5-c]quinoline have a broad cytoprotective activity which is mediated by several mechanisms including mitoprotection.
Collapse
Affiliation(s)
- Sushovan Jena
- Department of Chemistry, School of Advanced Sciences, Vellore Institute of Technology, Vellore, Tamil Nadu, 632014, India
| | - Gabriel Gonzalez
- Department of Experimental Biology, Palacky University Olomouc, Faculty of Science, Šlechtitelů 27, 78371, Olomouc, Czech Republic; Department of Neurology, University Hospital in Olomouc, I. P. Pavlova 6, 77520, Olomouc, Czech Republic
| | - Dominik Vítek
- Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University, Hněvotínská 5, 77515, Olomouc, Czech Republic
| | - Marie Kvasnicová
- Department of Experimental Biology, Palacky University Olomouc, Faculty of Science, Šlechtitelů 27, 78371, Olomouc, Czech Republic; Laboratory of Growth Regulators, Faculty of Science, Palacký University Olomouc, and Institute of Experimental Botany of the Czech Academy of Sciences, Šlechtitelů 27, CZ-78371, Olomouc, Czech Republic
| | - Šárka Štěpánková
- Department of Biological and Biochemical Sciences, Faculty of Chemical Technology, University of Pardubice, Studentská 573, 53210, Pardubice, Czech Republic
| | - Miroslav Strnad
- Laboratory of Growth Regulators, Faculty of Science, Palacký University Olomouc, and Institute of Experimental Botany of the Czech Academy of Sciences, Šlechtitelů 27, CZ-78371, Olomouc, Czech Republic
| | - Jiří Voller
- Department of Experimental Biology, Palacky University Olomouc, Faculty of Science, Šlechtitelů 27, 78371, Olomouc, Czech Republic; Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University, Hněvotínská 5, 77515, Olomouc, Czech Republic.
| | - Kaushik Chanda
- Department of Chemistry, Rabindranath Tagore University, Hojai, Assam, 782435, India.
| |
Collapse
|
2
|
Bernard PJ, Bellili D, Ismaili L. Calcium channel blockers' contribution to overcoming Current drug discovery challenges in Alzheimer's disease. Expert Opin Drug Discov 2024; 19:21-32. [PMID: 37800853 DOI: 10.1080/17460441.2023.2266994] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2023] [Accepted: 10/02/2023] [Indexed: 10/07/2023]
Abstract
INTRODUCTION Alzheimer's disease (AD) is a progressive, irreversible, and multifactorial brain disorder that gradually and insidiously destroys individual's memory, thinking, and other cognitive abilities. AREAS COVERED In this perspective, the authors examine the complex and multifactorial nature of Alzheimer's disease and believe that the best approach to develop new drugs is the MTDL strategy, which obviously faces several challenges. These challenges include identifying the key combination of targets and their suitability for coordinated actions, as well as developing an acceptable pharmacokinetic and toxicological profile to deliver a drug candidate. EXPERT OPINION Since calcium plays a crucial role in the pathology of AD, a polypharmacological approach with calcium channel blockers reinforced by activities targeting other factors involved in AD is a serious option in our opinion. This is exemplified by a phase III clinical trial using a drug combination approach with Losartan, Amlodipine (a calcium channel blocker), and Atorvastatin, as well as several MTDL-based calcium channel blockade approaches with a promising in vitro and in vivo profile.
Collapse
Affiliation(s)
- Paul J Bernard
- Université de Franche-Comté, LINC, UFR Santé, Pôle de Chimie Médicinale, Besançon, France
| | - Djamila Bellili
- Université de Franche-Comté, LINC, UFR Santé, Pôle de Chimie Médicinale, Besançon, France
| | - Lhassane Ismaili
- Université de Franche-Comté, LINC, UFR Santé, Pôle de Chimie Médicinale, Besançon, France
| |
Collapse
|
3
|
Haghipour S, Mehrdad M, Hosseini S, Moazzam A, Rad-Moghadam K, Mahdavi M. Ethyl 4-hydroxy-2-oxo-1,2-dihydroquinoline-3-carboxylate in the smiles rearrangement reaction: straightforward synthesis of amino acid derived quinolin-2(1H)-one enamines. Mol Divers 2023; 27:2345-2352. [PMID: 36752999 DOI: 10.1007/s11030-022-10560-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/17/2022] [Accepted: 10/29/2022] [Indexed: 02/09/2023]
Abstract
This paper describes the development of 4-hydroxy-2-oxo-1,2-dihydroquinoline-3-carboxylate compound as a heterocyclic enols containing a Michael acceptor so that it participates in an Ugi-type multicomponent condensation through a Smiles rearrangement in replacement of acid components. The new four-component containing 4-hydroxy-2-oxo-1,2-dihydroquinoline-3-carboxylate, aldehyde derivatives, amine derivatives and isocyanides process leads readily and efficiently to heterocyclic enamines. This report is an outstanding strategy for the preparation of new biologically structures containing peptidic or pseudo-peptidic with quinolin-2(1H)-one scaffolds.
Collapse
Affiliation(s)
- Sirous Haghipour
- Department of Chemistry, Faculty of Science, University of Guilan, Rasht, Iran
| | - Morteza Mehrdad
- Department of Chemistry, Faculty of Science, University of Guilan, Rasht, Iran.
| | | | - Ali Moazzam
- Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
| | | | - Mohammad Mahdavi
- Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
| |
Collapse
|
4
|
Multicomponent reactions as a privileged tool for multitarget-directed ligand strategies in Alzheimer's disease therapy. Future Med Chem 2022; 14:1583-1606. [PMID: 36263996 DOI: 10.4155/fmc-2022-0170] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
Among neurodegenerative pathologies affecting the older population, Alzheimer's disease is the most common type of dementia and leads to neurocognitive and behavioral disorders. It is a complex and progressive age-related multifactorial disease characterized by a series of highly interconnected pathophysiological processes. Within the last decade, the multitarget-directed ligand strategy has emerged as a viable approach to developing complex molecules that exhibit several pharmacophores which can target the different enzymes and receptors involved in the pathogenesis of the disease. Herein, we focus on using multicomponent reactions such as Hantzsch, Biginelli and Ugi to develop these biologically active multitopic ligands.
Collapse
|
5
|
Zaib S, Munir R, Younas MT, Kausar N, Ibrar A, Aqsa S, Shahid N, Asif TT, Alsaab HO, Khan I. Hybrid Quinoline-Thiosemicarbazone Therapeutics as a New Treatment Opportunity for Alzheimer's Disease‒Synthesis, In Vitro Cholinesterase Inhibitory Potential and Computational Modeling Analysis. Molecules 2021; 26:molecules26216573. [PMID: 34770983 PMCID: PMC8587653 DOI: 10.3390/molecules26216573] [Citation(s) in RCA: 17] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/15/2021] [Revised: 10/26/2021] [Accepted: 10/27/2021] [Indexed: 02/07/2023] Open
Abstract
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder and the leading cause of dementia worldwide. The limited pharmacological approaches based on cholinesterase inhibitors only provide symptomatic relief to AD patients. Moreover, the adverse side effects such as nausea, vomiting, loss of appetite, muscle cramps, and headaches associated with these drugs and numerous clinical trial failures present substantial limitations on the use of medications and call for a detailed insight of disease heterogeneity and development of preventive and multifactorial therapeutic strategies on urgent basis. In this context, we herein report a series of quinoline-thiosemicarbazone hybrid therapeutics as selective and potent inhibitors of cholinesterases. A facile multistep synthetic approach was utilized to generate target structures bearing multiple sites for chemical modifications and establishing drug-receptor interactions. The structures of all the synthesized compounds were fully established using readily available spectroscopic techniques (FTIR, 1H- and 13C-NMR). In vitro inhibitory results revealed compound 5b as a promising and lead inhibitor with an IC50 value of 0.12 ± 0.02 μM, a 5-fold higher potency than standard drug (galantamine; IC50 = 0.62 ± 0.01 μM). The synergistic effect of electron-rich (methoxy) group and ethylmorpholine moiety in quinoline-thiosemicarbazone conjugates contributes significantly in improving the inhibition level. Molecular docking analysis revealed various vital interactions of potent compounds with amino acid residues and reinforced the in vitro results. Kinetics experiments revealed the competitive mode of inhibition while ADME properties favored the translation of identified inhibitors into safe and promising drug candidates for pre-clinical testing. Collectively, inhibitory activity data and results from key physicochemical properties merit further research to ensure the design and development of safe and high-quality drug candidates for Alzheimer’s disease.
Collapse
Affiliation(s)
- Sumera Zaib
- Department of Biochemistry, Faculty of Life Sciences, University of Central Punjab, Lahore 54590, Pakistan;
- Correspondence: (S.Z.); (R.M.); (I.K.)
| | - Rubina Munir
- Department of Chemistry, Kinnaird College for Women, Lahore 54000, Pakistan; (S.A.); (N.S.); (T.T.A.)
- Correspondence: (S.Z.); (R.M.); (I.K.)
| | - Muhammad Tayyab Younas
- Department of Biochemistry, Faculty of Life Sciences, University of Central Punjab, Lahore 54590, Pakistan;
| | - Naghmana Kausar
- Department of Chemistry, University of Gujrat, Gujrat 50700, Pakistan;
| | - Aliya Ibrar
- Department of Chemistry, Faculty of Natural Sciences, The University of Haripur, Haripur 22620, Pakistan;
| | - Sehar Aqsa
- Department of Chemistry, Kinnaird College for Women, Lahore 54000, Pakistan; (S.A.); (N.S.); (T.T.A.)
| | - Noorma Shahid
- Department of Chemistry, Kinnaird College for Women, Lahore 54000, Pakistan; (S.A.); (N.S.); (T.T.A.)
| | - Tahira Tasneem Asif
- Department of Chemistry, Kinnaird College for Women, Lahore 54000, Pakistan; (S.A.); (N.S.); (T.T.A.)
| | - Hashem O. Alsaab
- Department of Pharmaceutics and Pharmaceutical Technology, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia;
| | - Imtiaz Khan
- Department of Chemistry, Manchester Institute of Biotechnology, The University of Manchester, 131 Princess Street, Manchester M1 7DN, UK
- Correspondence: (S.Z.); (R.M.); (I.K.)
| |
Collapse
|
6
|
Moussaoui O, Byadi S, Eddine Hachim M, Sghyar R, Bahsis L, Moslova K, Aboulmouhajir A, Rodi YK, Podlipnik Č, Hadrami EMEL, Chakroune S. Selective synthesis of novel quinolones-amino esters as potential antibacterial and antifungal agents: Experimental, mechanistic study, docking and molecular dynamic simulations. J Mol Struct 2021. [DOI: 10.1016/j.molstruc.2021.130652] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
|
7
|
Solvent-free one pot synthesis of 1,2-dihydroquinolines from anilines and acetone catalysed by MOF-199. RESULTS IN CHEMISTRY 2021. [DOI: 10.1016/j.rechem.2021.100097] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
|
8
|
Tehrani T, Meghdadi S, Salarvand Z, Tavakoli B, Eskandari K, Amirnasr M. An anthracene–quinoline based dual-mode fluorometric–colorimetric sensor for the detection of Fe 3+ and its application in live cell imaging. NEW J CHEM 2021. [DOI: 10.1039/d1nj00178g] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
A highly sensitive anthracene–quinoline based dual-mode sensor has been synthesized and used for the fluorometric and colorimetric detection of Fe3+ and in live cell imaging.
Collapse
Affiliation(s)
- Tahereh Tehrani
- Department of Chemistry
- Isfahan University of Technology
- Isfahan 8415683111
- Iran
| | - Soraia Meghdadi
- Department of Chemistry
- Isfahan University of Technology
- Isfahan 8415683111
- Iran
| | - Zohreh Salarvand
- Department of Chemistry
- Chemistry and Petrochemistry Research Center
- Institute of Standard and Industrial Research of Iran (ISIRI)
- Karaj 3174734563
- Iran
| | - Behnam Tavakoli
- Department of Chemistry
- Isfahan University of Technology
- Isfahan 8415683111
- Iran
| | - Kiamars Eskandari
- Department of Chemistry
- Isfahan University of Technology
- Isfahan 8415683111
- Iran
| | - Mehdi Amirnasr
- Department of Chemistry
- Isfahan University of Technology
- Isfahan 8415683111
- Iran
| |
Collapse
|
9
|
Pourshojaei Y, Eskandari K, Asadipour A. Highly Significant Scaffolds to Design and Synthesis Cholinesterase Inhibitors as Anti-Alzheimer Agents. Mini Rev Med Chem 2019; 19:1577-1598. [DOI: 10.2174/1389557519666190719143112] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/23/2018] [Revised: 06/02/2019] [Accepted: 06/25/2019] [Indexed: 12/19/2022]
Abstract
:
Alzheimer, a progressive disease, is a common term for memory loss which interferes with
daily life through severe influence on cognitive abilities. Based on the cholinergic hypothesis, and Xray
crystallographic determination of the structure of acetylcholinesterase (AChE) enzyme, the level of
acetylcholine (ACh, an important neurotransmitter associated with memory) in the hippocampus and
cortex area of the brain has a direct effect on Alzheimer. This fact encourages scientists to design and
synthesize a wide range of acetylcholinesterase inhibitors (AChEIs) to control the level of ACh in the
brain, keeping in view the crystallographic structure of AChE enzyme and drugs approved by the Food
and Drug Administration (FDA).
:
AChEIs have slightly diverse pharmacological properties, but all of them work by inhibiting the segregation
of ACh by blocking AChE. We reviewed significant scaffolds introduced as AChEIs. In some
studies, the activity against butyrylcholinesterase (BuChE) has been evaluated as well because BuChE
is a similar enzyme to neuronal acetylcholinesterase and is capable of hydrolyzing ACh. In order to
study AChEIs effectively, we divided them structurally into 12 classes and briefly explained effective
AChEIs and compared their activities against AChE enzyme.
Collapse
Affiliation(s)
- Yaghoub Pourshojaei
- Department of Medicinal Chemistry, Faculty of Pharmacy & Pharmaceutics Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran
| | - Khalil Eskandari
- Department of Medicinal Chemistry, Faculty of Pharmacy & Pharmaceutics Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran
| | - Ali Asadipour
- Department of Medicinal Chemistry, Faculty of Pharmacy & Pharmaceutics Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran
| |
Collapse
|
10
|
Duarte Y, Gutierrez M, Álvarez R, Alzate‐Morales JH, Soto‐Delgado J. Experimental and Theoretical Approaches in the Study of Phenanthroline-Tetrahydroquinolines for Alzheimer's Disease. ChemistryOpen 2019; 8:627-636. [PMID: 31139552 PMCID: PMC6528641 DOI: 10.1002/open.201900073] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/21/2019] [Revised: 04/11/2019] [Indexed: 01/06/2023] Open
Abstract
The imino-Diels-Alder reaction is one of the most common strategies in organic chemistry and is an important tool for providing a broad spectrum of biologically active heterocyclic systems. A combined theoretical and experimental study of the imino-Diels-Alder reaction is described. The new phenanthroline-tetrahydroquinolines were evaluated as cholinesterase inhibitors. Their cytotoxicity in human neuroblastoma SH-SY5Y cells was also evaluated. The theoretical results suggest that compounds formation in stages can be explained by endo cycloadducts under the established reaction conditions, thereby confirming experimental results obtained for percentage yield. These results allowed us to establish that pyridine substituent remarkably influences activation energy and reaction yield, as well as in acetylcholinesterase (AChE) activity. Among these derivatives, compounds with 4-pyridyl and 4-nitrophenyl showed favorable AChE activity and proved to be non-cytotoxic.
Collapse
Affiliation(s)
- Yorley Duarte
- Facultad de Ciencias de la Vida, Center for Bioinformatics and Integrative BiologyUniversidad Andrés BelloSantiago8370146Chile
- Laboratorio Síntesis Orgánica, Instituto de Química de Recursos NaturalesUniversidad de TalcaCasilla 747TalcaChile
| | - Margarita Gutierrez
- Laboratorio Síntesis Orgánica, Instituto de Química de Recursos NaturalesUniversidad de TalcaCasilla 747TalcaChile
| | - Rocío Álvarez
- Laboratory of Pharmacology, Faculty of PharmacyUniversidad de ValparaísoGran Bretaña 10932360102ValparaísoChile
- Centro de Investigación Farmacopea Chilena (CIFAR)ValparaísoChile
| | - Jans H. Alzate‐Morales
- Centro de Bioinformática y Simulación MolecularUniversidad de Talca2 Norte 685, Casilla 721Chile
| | - Jorge Soto‐Delgado
- Departamento de Ciencias Químicas, Facultad de Ciencias ExactasUniversidad Andres BelloQuillota 980Viña del MarChile
| |
Collapse
|
11
|
Gong CX, Liu F, Iqbal K. Multifactorial Hypothesis and Multi-Targets for Alzheimer’s Disease. J Alzheimers Dis 2018; 64:S107-S117. [DOI: 10.3233/jad-179921] [Citation(s) in RCA: 79] [Impact Index Per Article: 13.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Affiliation(s)
- Cheng-Xin Gong
- Department of Neurochemistry, Inge Grundke-Iqbal Research Floor, New York State Institute for Basic Research in Developmental Disabilities, Staten Island, NY, USA
| | - Fei Liu
- Department of Neurochemistry, Inge Grundke-Iqbal Research Floor, New York State Institute for Basic Research in Developmental Disabilities, Staten Island, NY, USA
| | - Khalid Iqbal
- Department of Neurochemistry, Inge Grundke-Iqbal Research Floor, New York State Institute for Basic Research in Developmental Disabilities, Staten Island, NY, USA
| |
Collapse
|
12
|
Chufarova N, Czarnecka K, Skibiński R, Cuchra M, Majsterek I, Szymański P. New tacrine-acridine hybrids as promising multifunctional drugs for potential treatment of Alzheimer's disease. Arch Pharm (Weinheim) 2018; 351:e1800050. [DOI: 10.1002/ardp.201800050] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2018] [Revised: 05/10/2018] [Accepted: 05/14/2018] [Indexed: 12/24/2022]
Affiliation(s)
- Nina Chufarova
- Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Drug Analyses and Radiopharmacy; Medical University of Lodz; Lodz Poland
| | - Kamila Czarnecka
- Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Drug Analyses and Radiopharmacy; Medical University of Lodz; Lodz Poland
| | - Robert Skibiński
- Faculty of Pharmacy, Department of Medicinal Chemistry; Medical University of Lublin; Lublin Poland
| | - Magda Cuchra
- Department of Clinical Chemistry and Biochemistry; Medical University of Lodz; Lodz Poland
| | - Ireneusz Majsterek
- Department of Clinical Chemistry and Biochemistry; Medical University of Lodz; Lodz Poland
| | - Paweł Szymański
- Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Drug Analyses and Radiopharmacy; Medical University of Lodz; Lodz Poland
| |
Collapse
|
13
|
Madkour HMF, El-Hashash MAEAM, Salem MS, Mahmoud ASOA. Synthesis, antileishmanial and cytotoxicity activities of fused and nonfused tetrahydroquinoline derivatives. RESEARCH ON CHEMICAL INTERMEDIATES 2018. [DOI: 10.1007/s11164-018-3311-6] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
|
14
|
Remennikov GY. Transformations of Di- and Tetrahydropyrimidine Derivatives into Condensed Heterocycles with Retention of their Partially Saturated Structure. J Heterocycl Chem 2017. [DOI: 10.1002/jhet.2852] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
|
15
|
Tetrahydropyranodiquinolin-8-amines as new, non hepatotoxic, antioxidant, and acetylcholinesterase inhibitors for Alzheimer's disease therapy. Eur J Med Chem 2017; 126:576-589. [DOI: 10.1016/j.ejmech.2016.11.050] [Citation(s) in RCA: 29] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2016] [Revised: 11/21/2016] [Accepted: 11/22/2016] [Indexed: 11/21/2022]
|
16
|
Barbosa FA, Canto RF, Saba S, Rafique J, Braga AL. Synthesis and evaluation of dihydropyrimidinone-derived selenoesters as multi-targeted directed compounds against Alzheimer’s disease. Bioorg Med Chem 2016; 24:5762-5770. [DOI: 10.1016/j.bmc.2016.09.031] [Citation(s) in RCA: 51] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/29/2016] [Revised: 09/09/2016] [Accepted: 09/12/2016] [Indexed: 11/29/2022]
|
17
|
Kwak SH, Kang JA, Kim M, Lee SD, Park JH, Park SG, Ko H, Kim YC. Discovery and structure–activity relationship studies of quinolinone derivatives as potent IL-2 suppressive agents. Bioorg Med Chem 2016; 24:5357-5367. [DOI: 10.1016/j.bmc.2016.08.051] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/26/2016] [Revised: 08/25/2016] [Accepted: 08/27/2016] [Indexed: 12/20/2022]
|
18
|
Li F, Wang ZM, Wu JJ, Wang J, Xie SS, Lan JS, Xu W, Kong LY, Wang XB. Synthesis and pharmacological evaluation of donepezil-based agents as new cholinesterase/monoamine oxidase inhibitors for the potential application against Alzheimer's disease. J Enzyme Inhib Med Chem 2016; 31:41-53. [PMID: 27384289 DOI: 10.1080/14756366.2016.1201814] [Citation(s) in RCA: 34] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
Abstract
In a continuing effort to develop multitargeted compounds as potential treatment agents against Alzheimer's disease (AD), a series of donepezil-like compounds were designed, synthesized and evaluated. In vitro studies showed that most of the designed compounds displayed potent inhibitory activities toward AChE, BuChE, MAO-B and MAO-A. Among them, w18 was a promising agent with balanced activities, which exhibited a moderate cholinesterase inhibition (IC50, 0.220 μM for eeAChE; 1.23 μM for eqBuChE; 0.454 μM for hAChE) and an acceptable inhibitory activity against monoamine oxidases (IC50, 3.14 μM for MAO-B; 13.4 μM for MAO-A). Moreover, w18 could also be a metal-chelator, and able to cross the blood-brain barrier with low cell toxicity on PC12 cells. Taken together, these results suggested that w18 might be a promising multitargeted compound for AD treatment.
Collapse
Affiliation(s)
- Fan Li
- a State Key Laboratory of Natural Medicines, Department of Natural Medicinal Chemistry, China Pharmaceutical University , People's Republic of China
| | - Zhi-Min Wang
- a State Key Laboratory of Natural Medicines, Department of Natural Medicinal Chemistry, China Pharmaceutical University , People's Republic of China
| | - Jia-Jia Wu
- a State Key Laboratory of Natural Medicines, Department of Natural Medicinal Chemistry, China Pharmaceutical University , People's Republic of China
| | - Jin Wang
- a State Key Laboratory of Natural Medicines, Department of Natural Medicinal Chemistry, China Pharmaceutical University , People's Republic of China
| | - Sai-Sai Xie
- a State Key Laboratory of Natural Medicines, Department of Natural Medicinal Chemistry, China Pharmaceutical University , People's Republic of China
| | - Jin-Shuai Lan
- a State Key Laboratory of Natural Medicines, Department of Natural Medicinal Chemistry, China Pharmaceutical University , People's Republic of China
| | - Wei Xu
- a State Key Laboratory of Natural Medicines, Department of Natural Medicinal Chemistry, China Pharmaceutical University , People's Republic of China
| | - Ling-Yi Kong
- a State Key Laboratory of Natural Medicines, Department of Natural Medicinal Chemistry, China Pharmaceutical University , People's Republic of China
| | - Xiao-Bing Wang
- a State Key Laboratory of Natural Medicines, Department of Natural Medicinal Chemistry, China Pharmaceutical University , People's Republic of China
| |
Collapse
|
19
|
Pandey S, Sonar PK, Saraf SK. Synthesis and characterization of novel conjugates of 4-[3-(aryl/heteroaryl)-3-oxo-propenyl]-benzaldehyde with thiazole and thiazolidinones as possible voltage-gated sodium channel blockers. Med Chem Res 2016. [DOI: 10.1007/s00044-016-1587-x] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
20
|
Tomassoli I, Herlem G, Picaud F, Benchekroun M, Bautista-Aguilera OM, Luzet V, Jimeno ML, Gharbi T, Refouvelet B, Ismaili L. Synthesis, regioselectivity, and DFT analysis of new antioxidant pyrazolo[4,3-c]quinoline-3,4-diones. MONATSHEFTE FUR CHEMIE 2016. [DOI: 10.1007/s00706-016-1660-7] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
21
|
Zaheer Z, Khan FAK, Sangshetti JN, Patil RH, Lohar KS. Novel amalgamation of phthalazine-quinolines as biofilm inhibitors: One-pot synthesis, biological evaluation and in silico ADME prediction with favorable metabolic fate. Bioorg Med Chem Lett 2016; 26:1696-703. [PMID: 26923699 DOI: 10.1016/j.bmcl.2016.02.057] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/11/2015] [Revised: 02/17/2016] [Accepted: 02/19/2016] [Indexed: 01/21/2023]
Abstract
A facile and highly efficient one-pot synthesis of phthalazine-quinoline derivatives is reported via four component reaction of phthalic anhydride, hydrazine hydrate, 5,5-dimethyl 1,3 cyclohexanedione and various quinoline aldehydes using PrxCoFe2-xO4 (x=0.1) nanoparticles as a catalyst. The synthesized compounds have been evaluated for anti-biofilm activity against Pseudomonas aeruginosa and Candida albicans. The compounds 12a (IC50=30.0μM) and 12f (IC50=34.5μM) had shown promising anti-biofilm activity against P. aeruginosa and C. albicans, respectively, when compared with standards without affecting the growth of cells (and thus behave as anti-quorum sensing agents). Compounds 12a (MIC=45.0μg/mL) and 12f (MIC=57.5μg/mL) showed significant potent antimicrobial activity against P. aeruginosa and C. albicans, respectively. Thus, the active derivatives were not only potent biofilm inhibitors but also efficient antimicrobial agents. In silico ADME and metabolic site prediction studies were also held out to set an effective lead candidate for the future antimicrobial drug discovery initiatives.
Collapse
Affiliation(s)
- Zahid Zaheer
- Dr. Rafiq Zakaria Campus, Y.B. Chavan College of Pharmacy, Aurangabad 431001, M.S., India.
| | - Firoz A Kalam Khan
- Dr. Rafiq Zakaria Campus, Y.B. Chavan College of Pharmacy, Aurangabad 431001, M.S., India
| | | | - Rajendra H Patil
- Department of Biotechnology, Savitribai Phule Pune University, Pune 411007, M.S., India
| | - K S Lohar
- Materials Research Laboratory, Srikrishna Mahavidyalaya Gunjoti, Omerga, Osmanabad 413 613, M.S., India
| |
Collapse
|
22
|
Mugnaini C, Brizzi A, Ligresti A, Allarà M, Lamponi S, Vacondio F, Silva C, Mor M, Di Marzo V, Corelli F. Investigations on the 4-Quinolone-3-carboxylic Acid Motif. 7. Synthesis and Pharmacological Evaluation of 4-Quinolone-3-carboxamides and 4-Hydroxy-2-quinolone-3-carboxamides as High Affinity Cannabinoid Receptor 2 (CB2R) Ligands with Improved Aqueous Solubility. J Med Chem 2016; 59:1052-67. [DOI: 10.1021/acs.jmedchem.5b01559] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Affiliation(s)
- Claudia Mugnaini
- Dipartimento
di Biotecnologie, Chimica e Farmacia, Università degli Studi di Siena, Via Aldo Moro 2, 53100 Siena, Italy
| | - Antonella Brizzi
- Dipartimento
di Biotecnologie, Chimica e Farmacia, Università degli Studi di Siena, Via Aldo Moro 2, 53100 Siena, Italy
| | - Alessia Ligresti
- Endocannabinoid
Research Group, Istituto di Chimica Biomolecolare, Consiglio Nazionale delle Ricerche, Via dei Campi Flegrei 34, 80078 Pozzuoli (Napoli), Italy
| | - Marco Allarà
- Endocannabinoid
Research Group, Istituto di Chimica Biomolecolare, Consiglio Nazionale delle Ricerche, Via dei Campi Flegrei 34, 80078 Pozzuoli (Napoli), Italy
| | - Stefania Lamponi
- Dipartimento
di Biotecnologie, Chimica e Farmacia, Università degli Studi di Siena, Via Aldo Moro 2, 53100 Siena, Italy
| | - Federica Vacondio
- Dipartimento
di Farmacia, Università degli Studi di Parma, Parco Area
delle Scienze 27/A, 43124 Parma, Italy
| | - Claudia Silva
- Dipartimento
di Farmacia, Università degli Studi di Parma, Parco Area
delle Scienze 27/A, 43124 Parma, Italy
| | - Marco Mor
- Dipartimento
di Farmacia, Università degli Studi di Parma, Parco Area
delle Scienze 27/A, 43124 Parma, Italy
| | - Vincenzo Di Marzo
- Endocannabinoid
Research Group, Istituto di Chimica Biomolecolare, Consiglio Nazionale delle Ricerche, Via dei Campi Flegrei 34, 80078 Pozzuoli (Napoli), Italy
| | - Federico Corelli
- Dipartimento
di Biotecnologie, Chimica e Farmacia, Università degli Studi di Siena, Via Aldo Moro 2, 53100 Siena, Italy
| |
Collapse
|
23
|
Dgachi Y, Ismaili L, Knez D, Benchekroun M, Martin H, Szałaj N, Wehle S, Bautista-Aguilera OM, Luzet V, Bonnet A, Malawska B, Gobec S, Chioua M, Decker M, Chabchoub F, Marco-Contelles J. Synthesis and Biological Assessment of Racemic Benzochromenopyrimidinimines as Antioxidant, Cholinesterase, and Aβ1−42Aggregation Inhibitors for Alzheimer's Disease Therapy. ChemMedChem 2016; 11:1318-27. [DOI: 10.1002/cmdc.201500539] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/18/2015] [Indexed: 11/08/2022]
Affiliation(s)
- Youssef Dgachi
- Laboratory of Applied Chemistry: Heterocycles, Lipids and Polymers; Faculty of Sciences of Sfax; University of Sfax; BP 802 3000 Sfax Tunisia
| | - Lhassane Ismaili
- Neurosciences Intégratives et Cliniques EA 481; Laboratoire de Chimie Organique et Thérapeutique, UFR SMP; Université de Franche-Comté; Université Bourgogne Franche-Comté; 19 rue Ambroise Paré 25000 Besançon France
| | - Damijan Knez
- Faculty of Pharmacy; University of Ljubljana; Aškerčeva 7 1000 Ljubljana Slovenia
| | - Mohamed Benchekroun
- Neurosciences Intégratives et Cliniques EA 481; Laboratoire de Chimie Organique et Thérapeutique, UFR SMP; Université de Franche-Comté; Université Bourgogne Franche-Comté; 19 rue Ambroise Paré 25000 Besançon France
| | - Hélène Martin
- Laboratory of Cell Toxicology, EA 4267; University of Franche-Comté; 19 rue Ambroise Paré 25030 Besançon France
| | - Natalia Szałaj
- Department of Physicochemical Drug Analysis; Jagiellonian University, Medical College; Medyczna 9 Street 30-688 Krakow Poland
| | - Sarah Wehle
- Pharmazeutische und Medizinische Chemie; Institut für Pharmazie und Lebensmittelchemie; Julius-Maximilians-Universität Würzburg; Am Hubland 97074 Würzburg Germany
| | - Oscar M. Bautista-Aguilera
- Neurosciences Intégratives et Cliniques EA 481; Laboratoire de Chimie Organique et Thérapeutique, UFR SMP; Université de Franche-Comté; Université Bourgogne Franche-Comté; 19 rue Ambroise Paré 25000 Besançon France
| | - Vincent Luzet
- Neurosciences Intégratives et Cliniques EA 481; Laboratoire de Chimie Organique et Thérapeutique, UFR SMP; Université de Franche-Comté; Université Bourgogne Franche-Comté; 19 rue Ambroise Paré 25000 Besançon France
| | - Alexandre Bonnet
- Laboratory of Cell Toxicology, EA 4267; University of Franche-Comté; 19 rue Ambroise Paré 25030 Besançon France
| | - Barbara Malawska
- Department of Physicochemical Drug Analysis; Jagiellonian University, Medical College; Medyczna 9 Street 30-688 Krakow Poland
| | - Stanislav Gobec
- Faculty of Pharmacy; University of Ljubljana; Aškerčeva 7 1000 Ljubljana Slovenia
| | - Mourad Chioua
- Laboratory of Medicinal Chemistry (IQOG, CSIC); C/Juan de la Cierva 3 28006 Madrid Spain
| | - Michael Decker
- Pharmazeutische und Medizinische Chemie; Institut für Pharmazie und Lebensmittelchemie; Julius-Maximilians-Universität Würzburg; Am Hubland 97074 Würzburg Germany
| | - Fakher Chabchoub
- Laboratory of Applied Chemistry: Heterocycles, Lipids and Polymers; Faculty of Sciences of Sfax; University of Sfax; BP 802 3000 Sfax Tunisia
| | - José Marco-Contelles
- Laboratory of Medicinal Chemistry (IQOG, CSIC); C/Juan de la Cierva 3 28006 Madrid Spain
| |
Collapse
|
24
|
Singh M, Silakari O. Design, synthesis and biological evaluation of novel 2-phenyl-1-benzopyran-4-one derivatives as potential poly-functional anti-Alzheimer's agents. RSC Adv 2016. [DOI: 10.1039/c6ra17678j] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
The development of Multi-Target Directed Ligands (MTDLs) has emerged as a promising approach for targeting the complex etiology of Alzheimer's disease (AD).
Collapse
Affiliation(s)
- Manjinder Singh
- Molecular Modeling Lab
- Department of Pharmaceutical Sciences and Drug Research
- Punjabi University
- Patiala
- India
| | - Om Silakari
- Molecular Modeling Lab
- Department of Pharmaceutical Sciences and Drug Research
- Punjabi University
- Patiala
- India
| |
Collapse
|
25
|
Bogdanov AV, Sadykov TI, Musin LI, Khamatgalimov AR, Krivolapov DB, Dobrynin AB, Mironov VF. Chemoselective oxidation of 1-alkenylisatins with m-chloroperbenzoic acid. Synthesis of new derivatives of isatoic anhydride. RUSS J GEN CHEM+ 2015. [DOI: 10.1134/s1070363215090030] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
26
|
Kwak SH, Kim MJ, Lee SD, You H, Kim YC, Ko H. Solid-phase synthesis of quinolinone library. ACS COMBINATORIAL SCIENCE 2015; 17:60-9. [PMID: 25437883 DOI: 10.1021/co5001585] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
Quinolinones have various biological activities, including antibacterial, anticancer, and antiviral properties. The 3-substituted amide quinolin-2(1H)-ones not only show antibacterial activity, but also act as immunomodulators, 5-HT4 receptor agonists, cannabinoid receptor inverse agonists, and AchE and, BuchE inhibitors. To investigate the potent biological activity of 3-substituted amide quinolin-2(1H)-ones, a large number of 3,5-amide substituted-2-oxoquinolinones were prepared by parallel solid-phase synthesis. The compound 5-amino-1-(4-methoxybenzyl)-2-oxo-1,2-dihydroquinoline-3-carboxylic acid was loaded onto 4-formyl-3,5-dimethoxyphenoxy (PL-FDMP) resin by reductive amination with high efficiency. Various building blocks were attached to the 3 and 5 positions to yield 3,5-disubstituted-2-oxoquinolinones with high purity and good yield. The ability some of these compound to inhibit the release of IL-1β, a cytokine involved in the immune response was measured, and they showed about 50% inhibition at 10 μM.
Collapse
Affiliation(s)
- Seung-hwa Kwak
- School
of Life Sciences, Gwangju Institute of Science and Technology (GIST), Gwangju 500-712, Republic of Korea
| | - Min jeong Kim
- School
of Life Sciences, Gwangju Institute of Science and Technology (GIST), Gwangju 500-712, Republic of Korea
| | - So-Deok Lee
- School
of Life Sciences, Gwangju Institute of Science and Technology (GIST), Gwangju 500-712, Republic of Korea
| | - Hyun You
- Department
of Medical System Engineering (DMSE), Gwangju Institute of Science and Technology, Gwangju 500-712, Republic of Korea
| | - Yong-Chul Kim
- School
of Life Sciences, Gwangju Institute of Science and Technology (GIST), Gwangju 500-712, Republic of Korea
- Department
of Medical System Engineering (DMSE), Gwangju Institute of Science and Technology, Gwangju 500-712, Republic of Korea
| | - Hyojin Ko
- School
of Life Sciences, Gwangju Institute of Science and Technology (GIST), Gwangju 500-712, Republic of Korea
| |
Collapse
|
27
|
Guzior N, Wieckowska A, Panek D, Malawska B. Recent development of multifunctional agents as potential drug candidates for the treatment of Alzheimer's disease. Curr Med Chem 2015; 22:373-404. [PMID: 25386820 PMCID: PMC4435057 DOI: 10.2174/0929867321666141106122628] [Citation(s) in RCA: 235] [Impact Index Per Article: 26.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/09/2014] [Revised: 09/29/2014] [Accepted: 10/30/2014] [Indexed: 12/19/2022]
Abstract
Alzheimer's disease (AD) is a complex and progressive neurodegenerative disorder. The available therapy is limited to the symptomatic treatment and its efficacy remains unsatisfactory. In view of the prevalence and expected increase in the incidence of AD, the development of an effective therapy is crucial for public health. Due to the multifactorial aetiology of this disease, the multi-target-directed ligand (MTDL) approach is a promising method in search for new drugs for AD. This review updates information on the development of multifunctional potential anti-AD agents published within the last three years. The majority of the recently reported structures are acetylcholinesterase inhibitors, often endowed with some additional properties. These properties enrich the pharmacological profile of the compounds giving hope for not only symptomatic but also causal treatment of the disease. Among these advantageous properties, the most often reported are an amyloid-β antiaggregation activity, inhibition of β-secretase and monoamine oxidase, an antioxidant and metal chelating activity, NOreleasing ability and interaction with cannabinoid, NMDA or histamine H3 receptors. The majority of novel molecules possess heterodimeric structures, able to interact with multiple targets by combining different pharmacophores, original or derived from natural products or existing therapeutics (tacrine, donepezil, galantamine, memantine). Among the described compounds, several seem to be promising drug candidates, while others may serve as a valuable inspiration in the search for new effective therapies for AD.
Collapse
Affiliation(s)
| | | | | | - Barbara Malawska
- Jagiellonian University, Medical College, Chair of Pharmaceutical Chemistry, Department of Physicochemical Drug Analysis, 30-688 Krakow, Medyczna 9, Poland.
| |
Collapse
|
28
|
Benchekroun M, Bartolini M, Egea J, Romero A, Soriano E, Pudlo M, Luzet V, Andrisano V, Jimeno ML, López MG, Wehle S, Gharbi T, Refouvelet B, de Andrés L, Herrera-Arozamena C, Monti B, Bolognesi ML, Rodríguez-Franco MI, Decker M, Marco-Contelles J, Ismaili L. Novel Tacrine-Grafted Ugi Adducts as Multipotent Anti-Alzheimer Drugs: A Synthetic Renewal in Tacrine-Ferulic Acid Hybrids. ChemMedChem 2014; 10:523-39. [DOI: 10.1002/cmdc.201402409] [Citation(s) in RCA: 58] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2014] [Indexed: 01/09/2023]
|
29
|
Ahmed N, Konduru NK, Ahmad S, Owais M. Design, synthesis and antiproliferative activity of functionalized flavone-triazole-tetrahydropyran conjugates against human cancer cell lines. Eur J Med Chem 2014; 82:552-64. [DOI: 10.1016/j.ejmech.2014.06.009] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/13/2014] [Revised: 05/27/2014] [Accepted: 06/05/2014] [Indexed: 12/25/2022]
|
30
|
Pudlo M, Luzet V, Ismaïli L, Tomassoli I, Iutzeler A, Refouvelet B. Quinolone–benzylpiperidine derivatives as novel acetylcholinesterase inhibitor and antioxidant hybrids for Alzheimer Disease. Bioorg Med Chem 2014; 22:2496-507. [DOI: 10.1016/j.bmc.2014.02.046] [Citation(s) in RCA: 38] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2013] [Revised: 02/20/2014] [Accepted: 02/24/2014] [Indexed: 10/25/2022]
|
31
|
Canto RFS, Barbosa FAR, Nascimento V, de Oliveira AS, Brighente IMC, Braga AL. Design, synthesis and evaluation of seleno-dihydropyrimidinones as potential multi-targeted therapeutics for Alzheimer's disease. Org Biomol Chem 2014; 12:3470-7. [DOI: 10.1039/c4ob00598h] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
We report the design, synthesis and evaluation of a series of seleno-dihydropyrimidinones as potential multi-targeted therapeutics for Alzheimer's disease.
Collapse
Affiliation(s)
- Rômulo F. S. Canto
- Laboratorio de Sintese de Substancias de Selenio Bioativas
- Centro de Ciencias Fisicas e Matematicas
- Departamento de Quimica
- Universidade Federal de Santa Catarina
- Florianopolis, Brazil
| | - Flavio A. R. Barbosa
- Laboratorio de Sintese de Substancias de Selenio Bioativas
- Centro de Ciencias Fisicas e Matematicas
- Departamento de Quimica
- Universidade Federal de Santa Catarina
- Florianopolis, Brazil
| | - Vanessa Nascimento
- Laboratorio de Sintese de Substancias de Selenio Bioativas
- Centro de Ciencias Fisicas e Matematicas
- Departamento de Quimica
- Universidade Federal de Santa Catarina
- Florianopolis, Brazil
| | - Aldo S. de Oliveira
- CFM
- Departamento de Quimica
- Universidade Federal de Santa Catarina
- Florianopolis, Brazil
| | - Inês M. C. Brighente
- CFM
- Departamento de Quimica
- Universidade Federal de Santa Catarina
- Florianopolis, Brazil
| | - Antonio Luiz Braga
- Laboratorio de Sintese de Substancias de Selenio Bioativas
- Centro de Ciencias Fisicas e Matematicas
- Departamento de Quimica
- Universidade Federal de Santa Catarina
- Florianopolis, Brazil
| |
Collapse
|
32
|
Yan L, Bjork P, Butuc R, Gawdzik J, Earley J, Kim G, Hofmann Bowman MA. Beneficial effects of quinoline-3-carboxamide (ABR-215757) on atherosclerotic plaque morphology in S100A12 transgenic ApoE null mice. Atherosclerosis 2013; 228:69-79. [PMID: 23497784 PMCID: PMC3640742 DOI: 10.1016/j.atherosclerosis.2013.02.023] [Citation(s) in RCA: 40] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/26/2012] [Revised: 02/18/2013] [Accepted: 02/19/2013] [Indexed: 02/04/2023]
Abstract
OBJECTIVE There is an emerging widespread interest in the role of damage-associated molecular pattern molecules (DAMP) S100A8, S100A9 and S100A12 in cardiovascular and other diseases. In this study we tested the efficacy of ABR-215757, a S100 protein binding immuno-modulatory compound to stabilize atherosclerosis in transgenic ApoE null mice that express the human pro-inflammatory S100A12 protein within the smooth muscle cell (SM22α-S100A12). METHODS Twelve-week old S100A12 transgenic/ApoE(-/-) and WT/ApoE(-/-) mice were treated with ABR-21575 for 5 weeks and were analyzed 4 month later. RESULTS Surface plasmon resonance analysis demonstrated that S100A12 interacts with ABR-215757 in a zinc dependent manner in vitro. In vivo, ABR-215757 administration reduced features of advanced plaque morphology resulting in smaller necrotic cores, diminished intimal and medial vascular calcification, and reduced amount of infiltrating inflammatory cells. ABR-215757 normalized aortic expression of RAGE protein and normalized experimentally-induced delayed hypersensitivity. The effect of ABR-215757 was more prominent in ApoE(-/-) mice expressing S100A12 than in ApoE(-/-) animals lacking expression of human S100A12 protein. CONCLUSION Our data suggest that S100A12 is important for progression of atherosclerosis and can be targeted by the small molecule ABR-215757. The specific binding of quinoline-3-carboxamides to S100A12 attenuates S100A12-mediated features of accelerated murine atherosclerosis.
Collapse
MESH Headings
- Animals
- Aorta, Thoracic/drug effects
- Aorta, Thoracic/pathology
- Aorta, Thoracic/physiology
- Apolipoproteins E/genetics
- Atherosclerosis/drug therapy
- Atherosclerosis/genetics
- Atherosclerosis/pathology
- Calgranulin B/metabolism
- Disease Models, Animal
- Humans
- Immunosuppressive Agents/pharmacology
- Mice
- Mice, Inbred C57BL
- Mice, Transgenic
- Plaque, Atherosclerotic/drug therapy
- Plaque, Atherosclerotic/genetics
- Plaque, Atherosclerotic/pathology
- Protein Binding/drug effects
- Protein Binding/physiology
- Quinolines/pharmacology
- Receptor for Advanced Glycation End Products
- Receptors, Immunologic/genetics
- Recombinant Proteins/genetics
- S100 Proteins/genetics
- S100 Proteins/metabolism
- S100A12 Protein
- Vasculitis/drug therapy
- Vasculitis/genetics
- Vasculitis/pathology
- Zinc/metabolism
Collapse
Affiliation(s)
- Ling Yan
- Department of Medicine, Section of Cardiology, The University of Chicago, IL, USA
| | - Per Bjork
- Active Biotech AB, Scheelev. 22, S-22363 Lund, Sweden
| | - Radu Butuc
- Department of Medicine, Section of Cardiology, The University of Chicago, IL, USA
| | - Joseph Gawdzik
- Department of Medicine, Section of Cardiology, The University of Chicago, IL, USA
| | - Judy Earley
- Department of Medicine, Section of Cardiology, The University of Chicago, IL, USA
| | - Gene Kim
- Department of Medicine, Section of Cardiology, The University of Chicago, IL, USA
| | | |
Collapse
|
33
|
Shivaraj Y, Naveen MH, Vijayakumar GR, Kumar DBA. Design, Synthesis and Antibacterial Activity Studies of Novel Quinoline Carboxamide Derivatives. JOURNAL OF THE KOREAN CHEMICAL SOCIETY-DAEHAN HWAHAK HOE JEE 2013. [DOI: 10.5012/jkcs.2013.57.2.241] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
|
34
|
Xie SS, Wang XB, Li JY, Yang L, Kong LY. Design, synthesis and evaluation of novel tacrine-coumarin hybrids as multifunctional cholinesterase inhibitors against Alzheimer's disease. Eur J Med Chem 2013; 64:540-53. [PMID: 23685572 DOI: 10.1016/j.ejmech.2013.03.051] [Citation(s) in RCA: 119] [Impact Index Per Article: 10.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/28/2013] [Revised: 03/21/2013] [Accepted: 03/24/2013] [Indexed: 02/01/2023]
Abstract
A series of tacrine-coumarin hybrids (8a-t) were designed, synthesized and evaluated as multifunctional cholinesterase (ChE) inhibitors against Alzheimer's disease (AD). The screening results showed that most of them exhibited a significant ability to inhibit ChE and self-induced β-amyloid (Aβ) aggregation, and to act as metal chelators. Especially, 8f displayed the greatest ability to inhibit acetylcholinesterase (AChE, IC50 = 0.092 μM) and Aβ aggregation (67.8%, 20 μM). It was also a good butyrylcholinesterase inhibitor (BuChE, IC50 = 0.234 μM) and metal chelator. Besides, kinetic and molecular modeling studies indicated that 8f was a mixed-type inhibitor, binding simultaneously to active, peripheral and mid-gorge sites of AChE. These results suggested that 8f might be an excellent multifunctional agent for AD treatment.
Collapse
Affiliation(s)
- Sai-Sai Xie
- State Key Laboratory of Natural Medicines, Department of Natural Medicinal Chemistry, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, People's Republic of China
| | | | | | | | | |
Collapse
|
35
|
Arunkhamkaew S, Athipornchai A, Apiratikul N, Suksamrarn A, Ajavakom V. Novel racemic tetrahydrocurcuminoid dihydropyrimidinone analogues as potent acetylcholinesterase inhibitors. Bioorg Med Chem Lett 2013; 23:2880-2. [PMID: 23583510 DOI: 10.1016/j.bmcl.2013.03.069] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/31/2012] [Revised: 03/11/2013] [Accepted: 03/21/2013] [Indexed: 12/25/2022]
Abstract
The synthesis of racemic tetrahydrocurcumin- (THC-), tetrahydrodemethoxycurcumin- (THDC-) and tetrahydrobisdemethoxycurcumin- (THBDC-) dihydropyrimidinone (DHPM) analogues was achieved by utilizing the multi-component Biginelli reaction in the presence of copper sulphate as a catalyst. The evaluation of acetylcholinesterase inhibitors for Alzheimer's disease of these compounds showed that they exhibited higher inhibitory activity than their parent analogues. THBDC-DHPM demonstrated the most potent inhibitory activity with an IC50 value of 1.34±0.03μM which was more active than the approved drug galanthamine (IC50=1.45±0.04μM).
Collapse
Affiliation(s)
- Sarawalee Arunkhamkaew
- Department of Chemistry and Center of Excellence for Innovation in Chemistry, Faculty of Science, Ramkhamhaeng University, Bangkok 10240, Thailand
| | | | | | | | | |
Collapse
|
36
|
Hu C, Liu SJ, Cui LB, Xu HL, Wang TY, Li S, Lin HQ, Chicheong Wan D. Design, Synthesis, and Biological Evaluation of 7H-Thiazolo[3,2-b]-1,2,4-triazin-7-one Derivatives as Dual Binding Site Acetylcholinesterase Inhibitors. HETEROCYCLES 2013. [DOI: 10.3987/com-13-12820] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
|
37
|
Montolio M, Gregori-Puigjané E, Pineda D, Mestres J, Navarro P. Identification of small molecule inhibitors of amyloid β-induced neuronal apoptosis acting through the imidazoline I(2) receptor. J Med Chem 2012; 55:9838-46. [PMID: 23098038 DOI: 10.1021/jm301055g] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Abstract
Aberrant activation of signaling pathways plays a pivotal role in central nervous system disorders, such as Alzheimer's disease (AD). Using a combination of virtual screening and experimental testing, novel small molecule inhibitors of tPA-mediated extracellular signal-regulated kinase (Erk)1/2 activation were identified that provide higher levels of neuroprotection from Aβ-induced apoptosis than Memantine, the most recently FDA-approved drug for AD treatment. Subsequent target deconvolution efforts revealed that they all share low micromolar affinity for the imidazoline I(2) receptor, while being devoid of any significant affinity to a list of AD-relevant targets, including the N-methyl-d-aspartate receptor (NMDAR), acetylcholinesterase (AChE), and monoamine oxidase B (MAO-B). Targeting the imidazoline I(2) receptor emerges as a new mechanism of action to inhibit tPA-induced signaling in neurons for the treatment of AD and other neurodegenerative diseases.
Collapse
Affiliation(s)
- Marisol Montolio
- Cancer Research Program, IMIM-Hospital del Mar Research Institute and University Pompeu Fabra, Parc de Recerca Biomèdica (PRBB), Doctor Aiguader 88, 08003 Barcelona, Catalonia, Spain
| | | | | | | | | |
Collapse
|
38
|
Szymański P, Lázničková A, Lázniček M, Bajda M, Malawska B, Markowicz M, Mikiciuk-Olasik E. 2,3-dihydro-1H-cyclopenta[b]quinoline derivatives as acetylcholinesterase inhibitors-synthesis, radiolabeling and biodistribution. Int J Mol Sci 2012; 13:10067-10090. [PMID: 22949848 PMCID: PMC3431846 DOI: 10.3390/ijms130810067] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Revised: 07/07/2012] [Accepted: 08/06/2012] [Indexed: 12/24/2022] Open
Abstract
In the present study we describe the synthesis and biological assessment of new tacrine analogs in the course of inhibition of acetylcholinesterase. The obtained molecules were synthesized in a condensation reaction between activated 6-BOC-hydrazinopyridine-3-carboxylic acid and 8-aminoalkyl derivatives of 2,3-dihydro-1H-cyclopenta[b]quinoline. Activities of the newly synthesized compounds were estimated by means of Ellman’s method. Compound 6h (IC50 = 3.65 nM) was found to be most active. All obtained novel compounds present comparable activity to that of tacrine towards acetylcholinesterase (AChE) and, simultaneously, lower activity towards butyrylcholinesterase (BChE). Apart from 6a, all synthesized compounds are characterized by a higher affinity for AChE and a lower affinity for BChE in comparison with tacrine. Among all obtained molecules, compound 6h presented the highest selectivity towards inhibition of acetylcholinesterase. Molecular modeling showed that all compounds demonstrated a similar binding mode with AChE and interacted with catalytic and peripheral sites of AChE. Also, a biodistribution study of compound 6a radiolabeled with 99mTc was performed.
Collapse
Affiliation(s)
- Paweł Szymański
- Department of Pharmaceutical Chemistry and Drug Analyses, Medical University, ul. Muszyńskiego 1, Lodz 90-151, Poland; E-Mails: (M.M.); (E.M.-O.)
- Author to whom correspondence should be addressed; E-Mail: ; Tel./Fax: +48-42-677-9250
| | - Alice Lázničková
- Faculty of Pharmacy in Hradec Kralove, Charles University in Prague, Heyrovskeho 1203, Hradec Kralove CZ-50005, Czech Republic; E-Mails: (A.L.); (M.L.)
| | - Milan Lázniček
- Faculty of Pharmacy in Hradec Kralove, Charles University in Prague, Heyrovskeho 1203, Hradec Kralove CZ-50005, Czech Republic; E-Mails: (A.L.); (M.L.)
| | - Marek Bajda
- Department of Physicochemical Drug Analysis, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, Krakow 30-688, Poland; E-Mails: (M.B.); (B.M.)
| | - Barbara Malawska
- Department of Physicochemical Drug Analysis, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, Krakow 30-688, Poland; E-Mails: (M.B.); (B.M.)
| | - Magdalena Markowicz
- Department of Pharmaceutical Chemistry and Drug Analyses, Medical University, ul. Muszyńskiego 1, Lodz 90-151, Poland; E-Mails: (M.M.); (E.M.-O.)
| | - Elżbieta Mikiciuk-Olasik
- Department of Pharmaceutical Chemistry and Drug Analyses, Medical University, ul. Muszyńskiego 1, Lodz 90-151, Poland; E-Mails: (M.M.); (E.M.-O.)
| |
Collapse
|
39
|
Turan-Zitouni G, Ozdemir A, Kaplancikli ZA, Altintop MD, Temel HE, Çiftçi GA. Synthesis and biological evaluation of some thiazole derivatives as new cholinesterase inhibitors. J Enzyme Inhib Med Chem 2012; 28:509-14. [DOI: 10.3109/14756366.2011.653355] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022] Open
Affiliation(s)
- Gülhan Turan-Zitouni
- Department of Pharmaceutical Chemistry, Anadolu University,
Faculty of Pharmacy, Eskişehir, Turkey
| | - Ahmet Ozdemir
- Department of Pharmaceutical Chemistry, Anadolu University,
Faculty of Pharmacy, Eskişehir, Turkey
| | - Zafer Asim Kaplancikli
- Department of Pharmaceutical Chemistry, Anadolu University,
Faculty of Pharmacy, Eskişehir, Turkey
| | - Mehlika Dilek Altintop
- Department of Pharmaceutical Chemistry, Anadolu University,
Faculty of Pharmacy, Eskişehir, Turkey
| | - Halide Edip Temel
- Department of Biochemistry, Anadolu University, Faculty of Pharmacy,
Eskişehir, Turkey
| | - Gülşen Akalın Çiftçi
- Department of Biochemistry, Anadolu University, Faculty of Pharmacy,
Eskişehir, Turkey
| |
Collapse
|